Monday, August 27, 2018


Today, the FDA issued a Federal Register notice proposing not to include three bulk drug substances, bumetanide, nicardipine hydrochloride, and vasopressin, on the list of bulk drug substances (or active pharmaceutical ingredients) that outsourcing facilities may use in compounding under section 503B of the Federal Food, Drug & Cosmetic Act (503B bulks list).

Sunday, August 26, 2018

Prince's family file new wrongful death lawsuit

Iosco County News Herald-19 hours ago
... a doctor who provided Prince with care at the hospital, and an unidentified pharmacist or pharmacy employee "that consulted" in the care provided to Princ

Opioid Lawsuits Looking More Like A Tobacco Settlement Every Day

Forbes-17 hours ago
“Manufacturers, distributors, pharmacy benefit managers (PBM) and retailers are all vulnerable but credit implications will vary with the greatest cash flow effects ...

Friday, August 24, 2018

Pharmacist Pleads Guilty To Distributing Oxycodone In Exchange For ...

CBS Baltimore-4 hours ago
BALTIMORE (WJZ) — A licensed pharmacist, Richard Daniel Hiller, 64, of Owings Mills, Md., pleaded guilty Friday to conspiracy to distributing oxycodone, and ...

FDA to Ban More Supplements? - Health Impact News

https://healthimpactnews.com/2018/fda-to-ban-more-supplements/
22 hours ago - The Pharmacy Compounding Advisory Committee (PCAC) advises the FDA in writing new rules regarding what supplements and drugs can be made .

FDA Plan to Combat Fraud by Compounders Would Boost Patient Safety The Pew Charitable Trusts · 7 hours ago

FDA Plan to Combat Fraud by Compounders Would Boost Patient Safety

The Pew Charitable Trusts · 7 hours ago

Thursday, August 23, 2018

FDA Awards Contract to Develop Opioid Use Guidelines

Pharmacy Practice News-10 hours ago
By Marie Rosenthal. With more than 40 people a day dying from an opioid overdose, the epidemic of opioid abuse in the United States is taking a staggering ...

What a no-deal Brexit might mean for pharmacy

The Pharmaceutical Journal-21 hours ago
Now, the Company Chemists' Association (CCA), which represents the big high street pharmacy chains, has told The Pharmaceutical Journal it is in discussions ...